Effects of Liraglutide on Glycemia, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
Status:
Completed
Trial end date:
2022-04-20
Target enrollment:
Participant gender:
Summary
The study aims to evaluate the effects of Liraglutide on glycemic control, serum markers of
inflammation, markers of endothelial dysfunction and a possible correlation with intra and
extra-hospital mortality rates in a group of hospitalized diabetic patients compared to a
control group of in-patient diabetic in treatment on insulin Basal-bolus.